Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA) AML blasts within diagnostic bone marrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results